Evaluating Safety of NovoPen® 3 and/or FlexPen® Devices in Routine Clinical Practice

Update Il y a 5 ans
Reference: NCT01454024

Woman and Man

  • | Country :
  • Pakistan
  • | organs :
  • -
  • | Specialty :
  • -

Extract

This study is conducted in Asia. The aim of of this study is to evaluate the safety of NovoPen® 3 and/or FlexPen® devices (if available on the market) measured by the number of adverse events and technical complaints in patients with type 1 and type 2 diabetes in routine clinical practice.


Inclusion criteria

  • diabetes ,Diabetes Mellitus, Type 1 ,Diabetes Mellitus, Type 2 ,Delivery Systems

Links